The Influence of day-to Day BPV on Long-term Adverse Outcomes in Patients Ischemic Stroke

NCT02663557 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2017-05-19

No results posted yet for this study

Summary

Stroke is one of the most devastating disorder worldwide. Hypertension has been confirmed to be a major modifiable risk factor for stroke.Even the casual visit hypertension has been managed ideally,there is still surplus risk for stroke re-attack.The purpose of this study is to explore whether variation of 24-hour ambulatory and visit-to-visit blood pressure variability (BPV) contribute to recurrent stroke.

Conditions

Sponsors & Collaborators

  • Zhu Shi

    lead OTHER_GOV

Principal Investigators

  • Zhu Shi, MD,PhD · dongguan peoples' hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2016-06-30
Completion
2017-03-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02663557 on ClinicalTrials.gov